FDA grants authorization to Moderna's Covid-19 vaccine(statnews.com) |
FDA grants authorization to Moderna's Covid-19 vaccine(statnews.com) |
[1] https://hn.algolia.com/?dateRange=all&page=0&prefix=true&sor...
One key advantage of the Moderna one versus the similar Pfizer/BioNTech vaccine is that it doesn't require deep freeze storage, only regular freezing temperatures. (-90º C for Pfizer/BioNTech vs -20º C for Moderna)
> Moderna spokesperson Colleen Hussey explained to NPR in an email that its vaccine doesn't need to be kept so cold because of its particular "lipid nanoparticle properties and structure," and because the company has learned from experience — it's developed ten mRNA vaccine candidates already. "Now we don't need [ultra-cold conditions] as the quality of product has improved and [it] doesn't need to be highly frozen to avoid mRNA degradation," Hussey explained.
and
> It's possible that Pfizer's vaccine could eventually be shown to be stable in somewhat warmer conditions — or for longer times out of the freezer.
1: https://www.npr.org/sections/health-shots/2020/11/17/9355633...
It may very well be that later on they'll change the freezing requirement later.
https://www.npr.org/sections/health-shots/2020/11/17/9355633...
I recall reading an article that mentioned -90C as the "safe shot", meaning they can be 100% certain that the vaccine is stable at this temp but it might be stable at much lower temps.
Also more BNT-XXX vaccines are in development.
Does these vaccines need an adjuvant to work, or is the change to the affected cells large enough to trigger an immune reaction?
The basic principle is to mix a solution with lipids and one with the mRNA and pump it through a channel with herringbone-shaped incisions that generate turbulence in the fluid. Apparently, the turbulence makes lipids surround the mRNA and stick together to form the nano-particle.
[1] http://www.future-science.com/doi/10.4155/tde-2016-0006
[2] https://science.sciencemag.org/content/295/5555/647.full
I wonder what the rate of lipid-surrounded mRNA is after the process. Say you fire 100 mRNAs through this construct, will 90 of them be surrounded by lipids afterwards? Or 30? Or 100?
We've all seen people advocating new wonderful technological solutions that fail because of unknown unknowns, in every field. That's just the rules of the R&D game.
In that case we're seriously thinking about injecting a new kind of drug to the whole world population based on a couple of short term trials, for a desease that is only lethal for far less than 1 percent of the population ( and in general, only the most fragile 1 percent).
I'm just like everyone and i find this new arn cell transcription machinery hacking absolutely insanely great. And i also think it looks safe from what the expert are explaining.
But is it safe enough to have it taken by everyone in the world ??
https://www.lesswrong.com/posts/Rvzdi8RS9Bda5aLt2/covid-12-1...
Professor Shane Crotty, PhD answers a series of COVID 19 vaccine questions including what are the chances of long-term side effects? How safe is RNA vaccine (i.e. Pfizer / BioNTech an Moderna Vaccines) technology? How long does mRNA from a vaccine stay in our cells? What else goes in vaccines? How long does immunity last? Why are T-Cells so important? Why does Pfizer's vaccine need to stay SO cold?
https://www.curevac.com/en/2020/12/14/curevac-commences-glob...
Also, given current high incidences I suspect phase 3 might be quite quick, which means Q3 or Q2 approval.
They may still play a role, as obviously the world won't be vaccinated within the next months. But they're also unlikely to play a role any time soon.
How could we research if the approval was politically motivated? How can I know if this is actually safe?
(1) https://www.vanityfair.com/news/2020/12/white-house-delays-p...
(2) https://www.wsj.com/articles/modernas-covid-19-vaccine-is-cl...
Next Moderna ... also super expensive second to be approved.
After six months to a year ... and after making huge profits....
Then the AstraZeneca/Russian vaccine variants will be “found” to be also effective.
We must first wait and let Pfizer make a few billion !!!
The case fatality rate would likely increase as we overwhelm healthcare resources, so it could be even worse.
1% may sound trivial but it becomes meaningful at the scale of a population. The benefits of the vaccine far outweigh the risks.
I was injected yesterday along with my fellow emergency department and ICU staff. People seemed giddy with hope and relieved to become protected. If you see enough people die of covid then the risk of the vaccine seems trivial.
I am fortunate enough to be a remote employee with little need (or desire) to interact in ways that I could spread or receive Covid-19, so I personally will wait a while for more data on safety and efficacy.
It won't get anywhere near that, as it doesn't take into account asymptomatic (I've seen estimates in some areas as high as 20:1, which would put the number dead at ~300k) and due to herd immunity not everyone is going to get infected anyway.
ICU beds are dollar for dollar the most expensive resource in healthcare today.
Not to mention the rarity of qualified healthcare workers who are trained in working in the ICUs and the risk of losing them for 2+ weeks if they get infected.
Additionally, other people will die at a higher percentage from other-than-covid reasons because covid patients are taking up all the resources, which can no longer be used to treat other patients.
The efficacy of the new mRNA vaccines is fantastic. It's a no-brainer to give them to people with a high likelihood of having a serious covid case.
Maybe it's justified to also give it to everyone else, to mitigate the economic effects of the epidemic. But asking this question is qualitatively different than what you hear from people who are normally skeptical towards vaccines. This is a completely new type of prophylactic, there is potential of an unknown unknown.
I'm typing this contrarian comment mostly to document that I've thought about it, in case, heaven forbid, we make a horrible discovery about it in 2025.
Honestly - aren't there researchers working in the field thinking similar thoughts? Is it such a taboo interjection that they don't dare speak it out loud out of fear of being compared to antivaxxers? I don't believe that it's an excessively cautious concern.
If we never questioned ourselves we'd still be using bloodletting as medical treatment.
Also: the implication of your statement about the "most fragile 1 percent" is that their lives are worth less than others. I cannot begin to describe the disgust I am feeling towards such an inhumane attitude.
it's called a tradeof , and public policies is doing it all the time, including accepting people dying for the greater good of others. Otherwise we would have banned cars a long time ago.
I do not know what the long term effects of the glass of water I just drunk will be.
This isn't a matter of water flowing downhill through a pipe or a piston moving through a cylinder. Although we have a good understanding of the process, we don't have decades of extensive engineering experience to give us empiric reassurance that there are no gotchas. We didn't put a billion people into airplanes nine months after the first commercial airliner was developed.
Sure, hopefully our current understanding is good enough and there are no long-term side effects. But it's naïve to assume a likelihood of 100%.
Although the elderly and sick have a high likelihood of a serious covid case, young and healthy people are exceedingly likely to have a mild disease. These probabilities are what you have to judge the confidence of long-term vaccine safety against.
Alternative: if we don't know it's safe, better have everyone take it, or at least as many as possible. That way there's no reliable control group to compare outcomes, and no one can blame the vaccine, and it's easier to blame other external factors or say we don't know.
This is (systemically) the general approach taken with many environmental toxins. It's only when unfortunate, acute "cancer clusters" etc appear that some really nasty chemicals which are prevalent everywhere - like PFAS, etc - come to attention.
“Yes, Moderna’s vaccine prevents transmission. One dose is good for reducing infection by 63%, two by over 90%.”
The number of people you need to vaccinate with a 63% effective vaccine versus a 90% effective vaccine is a huge gap.
There are two issues with vaccines that staring at these numbers won’t tell you:
1. Not everyone is going to get vaccinated.
2. The number of people who will get vaccinated is directly correlated with public trust.
If you release a vaccine that is 63% effective, the “this vaccine doesn’t work crowd” and their hugely amplified voices on YouTube and social media will be exponentially worse.
That snowballs into fewer people being vaccinated. Unlikely for us, with a less effective vaccine we need far more people being vaccinated.
So you want a more effective vaccine because fewer people need to get vaccinated, more people will trust the vaccine, and more people will get vaccinated.
(To pre-empt the bad-faith replies, this does _not_ mean we would sacrifice another six months to get a 98% effective vaccine (if it were possible) versus starting now. It’s a balance, of course.)
Also very important is that a second dose isn’t just for effectiveness, it’s to boost the immune system’s response so that the conferred immunity lasts significantly longer.
[0]: I struggled through this article. I find this self-congratulating “I’m smarter than everyone and I told you so in this other blog post” writing insufferable.
This is not something new or special. And people being ignorant should not change how things are properly done. Yes, they're going to freak, but it's because they're idiots. Don't base behavior on what they think. Accomidating them will not change their behavior at all. Their behavior does not reflect external realities.
The argument is that while there is a vaccine shortage, it is better to give as many as possible one dose, instead of giving only half that many people two doses, leaving the rest unprotected.
When available, everyone gets the second shot, which should work just as well 6 months later.
In animal studies, the second dose was required for a durable response, that's why Pfizer decided to go with it in their trial.
Given that's what they trialled, there really isn't a mechanism that would allow either them or the FDA to change the protocol from what was tested.
Yes, this is annoying. You can make that educated guess and not show up for your second shot and you'll probably help someone.
But medicine has a long history of people being rather convinced of theories that made an awful lot of sense and killed an awful lot of people.
At some point, they noticed. The double-blind trial became not just the preferred method or something like that. It became absolute gospel. Anything else is considered the GOTO of injecting people with... stuff: Even if it's exactly what you believe is needed right now, it's just not going to happen.
See also: "masks don't work" ( = "even though it sounds like a good idea, there is just as much actual evidence for their usefulness in preventing viral diseases right now, January 2020, as there is for crystal healing. Give us a month and we'll have data")
That works for both sides, both the true believers and the skeptics. Both sides are absolutely convinced that they are right and the other side's belief will kill people. At least one side is wrong. Both have their reasons, both appeal to history, both appeal to science. It is a confusing time to live.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6...
Depending on supply forecasts, it might be worth running a new trial to get a better handle on the efficacy of a single dose, but going that route now would definitely be a gamble. Especially since we're formulating this single dose hypothesis after having run the experiment and seen the results, which is always a dangerous approach.
Still, the data do seem to suggest that it's very plausible that a single dose would be sufficient. If things get bad enough, or supply is low enough, maybe that's a gamble worth taking.
In this case it may sound like too much nitpicking, but the general principle is that you don't roll out something you haven't tested in a trial. In general this is a good principle. I hope they'll do trials comparing single to double-dose soon.
Also they illegally marketed their psychotic drugs to children under kickbacks from doctors https://abcnews.go.com/Politics/Health/astrazeneca-pay-520-m...
AZ accidentally ran their first trial with only half the intended dose. For some reason, this turned out to work better than the intended regimen (90 % vs 60 % in the other trial).
When they noticed the mistake, they pretended it had been their intention all along.
That's one troubling error, one surprising result that doesn't fit expectations and could, therefore, indicate other, potentially dangerous, problems in thinking or execution, and one deliberate lie.
Personally, I'd tend to agree with you and would probably take their vaccine if offered.
But that's something entirely different than allowing it to be given to millions of people. Getting this wrong would lead to a total breakdown of trust in institutions, and, in due course, a few democracies as well.
To insinuate some conspiracy given these circumstances is evidence for the mechanism of that breakdown, as well as irresponsible and, frankly, amateur populism.
The difference isn't actually statistically significant. It's probably 60-70% effective overall.
How would you propose doing this without drawing blood from every single person getting a vaccine?
If you're worried that it was rushed by US politics: the "Pfizer" vaccine was made by Biontech, a German company, and has also been accepted (earlier, even) by regulators in Canada and the UK.
Have there been a lot of disease outbreaks preventable with an mRNA vaccine before? To make a product, you need customers. Whatever research we did to deal with SARS and MERS became moot when people stopped spreading the diseases; maybe Moderna could have delivered a vaccine, but there would have been no customers because other containment measures limited the spread.
My outsider impression of Moderna is that they had all the technology ready to deal with something like COVID-19, but there was no COVID-19 until now.
The fact that Pfizer/BioNTech independently produced a similar product on a similar timeframe is a pretty good indication that the technology was ready, and was just waiting for a market.
The analysis of the clinical trial was published in a very reputable and peer reviewed scientific journal [1,2].
> How can I know if this is actually safe?
In the reports [1,2].
If you believe that data is fake then I am afraid you just not want to be convinced.
[1] https://www.nature.com/articles/s41586-020-2622-0 [2] https://pubmed.ncbi.nlm.nih.gov/32991794/
Yep, it's definitely not the logical reason but Big Pharma and the US government and Germany at it again.
600 million doses would cost $25 billion, a trifle compared to how much the pandemic is costing.
This is the list of what the EU is paying:
Oxford/AstraZeneca: €1.78 (£1.61)
Johnson & Johnson: $8.50 (£6.30)
Sanofi/GSK: €7.56
Pfizer/BioNTech: €12
CureVac: €10
Moderna: $18
https://www.theguardian.com/world/2020/dec/18/belgian-minist...If we are serious about vaccination worldwide and quickly ... then this should already be approved IMO
https://www.bmj.com/content/371/bmj.m4037
So, from what I can tell. It isn't proven to disrupt transmission or reduce hospitalisation/death. It would require much larger or longer studies, which they have opted not to do.
We should also stop all research.
(I was going to also sarcastically suggest disbanding the military. But that actually happens to sort-of work along the lines you have in mind, because we can disarm tit-for-tat along with everyone else. So what we really need is for COVID to evolve faster, until it is capable of negotiating a truce and make strategic decisions)
If what I wrote is correct I don't see how it lends itself to "stop all research" as opposed to "wait until we have a more effective vaccine." I'm not even saying it's a greater than 50% probability, but it is a risk.
Do you have clinical evidence for that? I doubt it. OP still has a more valid point. Public trust in the vaccine and its apparent effectiveness ASAP after the vaccination campaign begins will be gigantic factors in its success.
We all know that a hard lockdown brings down the new-infection numbers WEEKS after beginning the lockdown, yet there are still a lot of people on Twitter, YT and at demonstrations (at least here in Germany) where folks are angry that the lockdown doesn't work 2 DAYS after its beginning.
The amount of truly wary/ignorant people out there is around 5-15% of the entire population in Germany and handing out a 63%-effective vaccine will be fuel to their bullshit stories.
I wish people would start taking this more seriously. We have a huge chunk of the population (5-15%) where discussions don't work anymore because their arguments aren't based in a common reality (e.g. "viruses exist and may pose a threat" is surprisingly often not a supported opinion).
In the spirit of understanding, in your words what are the biggest arguments against forcing a hard lock down?
I'm no epidemiologist, but I understand this is the how booster vaccine shots typically work.
I care less about public trust and the PR angle, and more about getting as many people protected as possible. If dumb people say dumb things matter much less.
In countries with actually working contact tracing you have regular cases from restaurants and doctor offices. For example
(meaning: I was trying to reenact a scene from the beginning of (gestures around) all this)
That paper: June 2020
If the argument towards this question is overwhelming, surely someone has made a lecture on it somewhere.
I think it might be because people are confusing asking questions with being against something. I am neither against vaccines nor mRNA vaccines particularly. I just genuinely want to learn the details. I think it is important to know upsides and downsides of each vaccine out there since there are several alternatives.
The mRNA is delivered, causes cells to express proteins and is naturally broken down (it's normal for the body to sweep up mRNAs over time).
Once the mRNA is gone, the long term effect is the immunity, which there's no reason to expect it to be different than immunity to similar antigens, which is something that is well studied.
So the immunity side of it is not a radical departure (antigens are presented to the body) and the delivery/mechanism is quite clear and has a natural brake (mRNA degradation).
There is simply no way to correctly assess the risk, unless you think that ARN therapy is a known technique. Which it clearly isn't.
Most countries in asia already ask for a negative PCR test for tourists, and some (like malaysia) have been in lockdown for almost the whole year despite having had less than a thousand casualties in total.
I wouldn't be surprised if madness reaches another level very soon.
In order to justify your stability, you need data to submit to the FDA (they don't take your word for it). When doing your initial stability studies, you try and collect data for the most ideal conditions - no refrigeration needed, stable for X years from room temperature to 30C (to account for conditions during shipment).
No doubt Pfizer lined up a number of early stability studies testing -80C, -50C, -20C, 0C, etc. They recognize that needing a -70C cold chain is a logistics hurdle. If they could avoid it at all, they would have pushed for it and had data to back it up.
How do you get this data for a large value of X without having to wait X years?
Though in practice it’s more complicated. Basically, make predictions based on accelerated testing and then validate them in real time tests. So, if things hold up at 3 and 6 months real time you can probably trust them over longer timeframes.
Let's keep things in perspective, please. This EUA is for Moderna's first product with any approval whatsover from the FDA. The lipid coating is a way for encasing the mrna vaccine in a kind of plastic for entering the cell.
Most people probably are at lower risk, but some people are dying from reinfection. They certainly weren’t.
Pfizer specifically rejected government funding. It did so because it didn’t want to be dragged into bureaucracy.
https://www.bundesregierung.de/breg-de/themen/themenseite-fo...
But what's also correct is: neither Pfizer nor BioNTech did accept money from the Trump government (except as payment for the finished product once it was approved of course), which is what the OP probably meant. There's a huge difference regarding the potential for politicization between this particular government and any other sane government on this planet, and especially the German one that's currently being led by a trained physicist.
Hundreds of billions is not accurate either though.
You'll need an high amount in PCR, i.e. low cycle threshold for the probability to be high.
Antigen tests will show if there was/is an infection.
PCR does not show infection only presence. (WHO has now put out guidance about this. They don't have to it's well known.)
If you're European this may be strange to you but I'm the U.S. we don't receive the cycle count when the RNA for the virus is detected.
Here's Fauci talking about it a little: https://youtu.be/a_Vy6fgaBPE&t=4m30s
I don't believe your logic follows. There's a lot riding on this vaccine working as advertised, thus there is considerable pressure on Pfizer/BioNTech to deliver on that promise. If they know their vaccine is at peak effectiveness when transported at -90ºC and that the effectiveness drops if handled at lower temperatures, and if time is critical as it is, then they have all the reasons in the world to just play it safe by going with the costly but reliable option.
Moderna's vaccine was the second to enter the US market. If Pfizer/BioNTech delayed their vaccine to work on lowering the temperature requirements, Moderna would eat their lunch, and Pfizer/BioNTech would be relegated to second place on the place it matters the most: the history books.
As is, I'm sure that Pfizer/BioNTech are already working on improving temperature requirements, while leading the race.
> This gives us three options, Is it Moderna taking more risks, Pfizer being more risk-averse or is the Moderna one inherently more stable?
I have zero insight on the situation, thus I can't really tell. However, it's clear that each and every single actor in the story, from biotech companies to politicians and also regulatory bodies, is taking way more risks on this issue than what they would otherwise take.
(I have no idea if that was the case here or not)
It is intellectually vapid to get worked about the fact companies are making a $15 marginal unit profit on a vaccine that has 10x the utility of the average annual physical but costs 1/10th as much.
Honestly a bit shocked based on the results and the number of lives that could be saved by effectively doubling the number of available doses that they didn’t try to get it modified to a single dose regimen.
Seems to me like just another way the FDA has screwed up this whole rollout.
As for the hospitalization and ICU, those numbers are inflated, but regardless, in order to pass the trial, the same number of people need to be infected in the trial. The only difference is that while you're waiting for a few dozen people to be infected naturally because you gave them a placebo, millions are being infected and thousands are dying daily.
Where’s your source on them being inflated?
> https://www.thelancet.com/journals/lanres/article/PIIS2213-2...
I imagine they will do what they did for the vaccine candidate ChAdOx1 nCoV-2019 and swab at least every week to test for infection.
Do you have any source to back up your claim that a challenge trial wouldn’t work for SARS-CoV-2?
The only way to do it and get real results is to use a challenge trial only on the elderly population where the asymptomatic rate is low and where the symptoms are exaggerated. This would mean though that if the vaccine didn’t work you would overwhelm the hospital system with a lot of sick elderly people who require the most care, when the healthcare system is already overwhelmed.
Being ethical and getting results are not the same thing.
They're saying that the differences are secret, and they're not gonna release the specific structure of the LNPs and why the differences are there. The equivalent of having two proprietary binaries that both accomplish the same task, but have different code, and the reasons why are secret as well.
And we're accepting this on the first mRNA vaccine ever to be used on a massive scale, all to protect their profits before the rest of the world can start producing vaccines. Yes they spent a lot of money and time creating the vaccine. Now open source it and let the rest of the world save their citizens.
And who’s going to pay for it? The whole PPE shortage was exactly because of this entitled attitude. If you artificially limit prices, you’ll only limit the supply (to possibly nothing, as vaccines have high upfront costs), and enable scalpers.
One obvious solution is to have a UN initiative that buys the IP and opensources it. I don’t know how hard this is. Generally, one big problem is the lack of gratitude on the part of freeriders. Otherwise, the goodwill it generated for the sponsors would probably be enough to make it happen.
PS: I live in Iran. I am not defending my privilege here.
Sure, they could have shared all their secrets, and BioNTech theirs. Then, they would have come up with the same vaccine candidate and run two identical trials. Which would've been quite useless and far more risky.
Their ethics say the ends justify the means.
https://www.sec.gov/Archives/edgar/data/1682852/000119312518...
"Most of our investigational medicines are formulated and administered in an LNP which may lead to systemic side effects related to the components of the LNP which may not have ever been tested in humans. While we have continued to optimize our LNPs, there can be no assurance that our LNPs will not have undesired effects. Our LNPs could contribute, in whole or in part, to one or more of the following: immune reactions, infusion reactions, complement reactions, opsonation reactions, antibody reactions including IgA, IgM, IgE or IgG or some combination thereof, or reactions to the PEG from some lipids or PEG otherwise associated with the LNP. Certain aspects of our investigational medicines may induce immune reactions from either the mRNA or the lipid as well as adverse reactions within liver pathways or degradation of the mRNA or the LNP, any of which could lead to significant adverse events in one or more of our clinical trials. Many of these types of side effects have been seen for legacy LNPs. There may be resulting uncertainty as to the underlying cause of any such adverse event, which would make it difficult to accurately predict side effects in future clinical trials and would result in significant delays in our programs"
vs.
"may lead" / "may not have", "can be no assurance that [they] will not" / "could contribute" / etc.
This virus seems to have the unique ability to cause cognitive impairments at a distance.
The latter would require another phase2/phase3 trial I assume, and you'd think they would've tested the former by now thoroughly.
If Pfizer has a short-list of candidates back in May, they could have had 6 months of stability data at approval.
They can keep those studies going and by next May have 12 months of data for the FDA to review and potentially update the transportation and storage requirements.
https://www.pharmacytimes.com/news/some-medications-last-lon...
https://www.astho.org/Programs/Preparedness/Public-Health-Em...